Within the past few years, increasing concerns have arisen about the ways in which corporate sponsorship of clinical trials and continuing medical education activities may bias the information that is published and disseminated about the benefits and risks of medications. Questions have also been raised about the extent of industry influence on the American Psychiatric Association’s diagnostic and treatment guidelines—namely, its DSM and Clinical Practice Guidelines.
Undue Pharmaceutical Influence on Psychiatric PracticeCounseling and School Psychology Faculty Publication Series
Community Engaged/ServingNo, this is not community-engaged.
PublisherUBM Medica LLC
Citation InformationCosgrove, Lisa and Harold J. Bursztajn, "Undue Pharmaceutical Influence on Psychiatric Practice" Psychiatric Times (May 18, 2010).